Organoids Services Market Size and Forecast (2021 – 2031)
Organoids Services Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
$3,633 – $6,433
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Organoids are simple tissue-engineered cell-based in vitro models that recapitulate many aspects of the complex structure and function of the corresponding in vivo tissue. They can be dissected and interrogated for fundamental mechanistic studies on development, regeneration and repair in human tissues, and can also be used in diagnostics, disease modelling, drug discovery and personalized medicine.
North America dominates the organoids services market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid services market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023–2031.
Increasing Key Developments to Provide Market Opportunities in Future
The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:
• In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products as needed.
• In May 2024, InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics’ 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research.
• In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.
• In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.
• In December 2022, Molecular Devices, LLC. acquired Cellesce Ltd. This acquisition focuses on producing large-scale PDOs for various purposes, including drug screening, through contract development and production services.
• In August 2021, STEMCELL Technologies and Hubrecht Organoid Technology (HUB) signed an agreement. As a part of this agreement, STEMCELL’s Contract Assay Services division began providing its tissue-derived organoids, such as lung, intestinal, and liver organoids, for pre-clinical toxicology screening and non-cancer drug development services to HUB. These services would facilitate the integration of organoids into preclinical testing programs by researchers and drug development organizations to aid in the faster and more economical launch of new therapies.
Such key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid services market growth..
Application -Based Insights
By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031.
Source -Based Insights
Based on source, the organoids services market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.
Organoids services Market: Competitive Landscape and Key Developments
Sino Biological Inc.; Eurofins Scientific SE; Molecular Devices, LLC.; InSphero; Cyprio; InnoSer; LABTOO; CUSABIO TECHNOLOGY LLC; Oncodesign Services; and HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key companies operating in the organoids services market.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the organoids services market report.
Summary Info
Industry: | |
---|---|
Pricing options: | |
Geographical coverage: | |
Year of Publication: |
According to our new research study on “Organoids Services Market Forecast to 2031 – Global Analysis – by Type, Application, Source, and Geography,” the market was valued at US$ 3.03 billion in 2023 and is projected to reach US$ 15.01 billion by 2031; it is expected to register a CAGR of 22.3% during 2023–2031. Factors contributing to the organoids services market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.
Organoids are emerging as a powerful asset for researchers and drug developers as they seek more efficient and accurate methods to identify promising drug candidates and predict their efficacy. The ability to generate patient-derived organoids opens up exciting possibilities for personalized drug screening. Organoids serve as realistic and relevant models for drug screening compared to traditional 2D cell cultures. They mimic the complexity of human organs, including their cellular composition, structure, and function, providing a more accurate representation of drug responses in the human body. This enables researchers to identify potential drug candidates more confidently and avoid costly and time-consuming failures in clinical trials. The organoid services market is experiencing rapid growth owing to the increasing demand for innovative screening services.
By creating organoids from a patient’s cells, researchers can tailor drug testing to individual responses, improving the likelihood of treatment success through a personalized approach. The integration of advanced technologies, such as high-throughput screening platforms and automated image analysis, further enhances the capabilities of organoid screening services. With the integration of high-throughput screening and organoids, researchers can test many drug compounds efficiently, analyze results more accurately, and accelerate the drug discovery process. Thus, the global focus on innovative screening services, driven by the popularity of personalized medicine and the need for faster drug development, favors the growth of the organoids services market. In January 2024, HUB Organoids (HUB) launched IntegriGut Screen for the global market. This innovative screening service employs patient-derived organoid (PDO) Monolayers—-organoid monolayers derived from inflammatory bowel disease (IBD) patients—allowing access to high-quality human data on epithelial barrier function and accelerating the development of novel IBD therapies.
Based on type, the organoids services market is classified into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the market in 2023, and it is further anticipated to register the highest CAGR during the forecast period.
By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031.
Based on source, the organoids services market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.
Sino Biological Inc.; Eurofins Scientific SE; Molecular Devices, LLC.; InSphero; Cyprio; InnoSer; LABTOO; CUSABIO TECHNOLOGY LLC; Oncodesign Services; and HUB Organoids B.V. (Hubrecht Organoid Technology) are among the leading companies operating in the global organoids services market.
Companies operating in the organoids services market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the organoids services market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall organoids services market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the organoids services market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the organoids services market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Organoids Services Market Landscape
4.1 PEST Analysis
5. Organoids Services Market – Key Market Dynamics
5.1 Organoids Services Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Demand for Innovative Drug Screening Services
5.2.2 Surge in Popularity of Personalized Drugs
5.3 Market Restraints
5.3.1 Dearth of Skilled Professionals
5.4 Market Opportunities
5.4.1 Increasing Key Developments
5.5 Future Trends
5.5.1 Integration of Artificial Intelligence
5.6 Impact of Drivers and Restraints:
6. Organoids Services Market – Global Market Analysis
6.1 Organoids Services Market Revenue (US$ Million), 2021–2031
6.2 Organoids Services Market Forecast Analysis
7. Organoids Services Market Analysis – by Type
7.1 Intestine
7.1.1 Overview
7.1.2 Intestine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Liver
7.2.1 Overview
7.2.2 Liver: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Stomach
7.3.1 Overview
7.3.2 Stomach: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Pancreas
7.4.1 Overview
7.4.2 Pancreas: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Lung
7.5.1 Overview
7.5.2 Lung: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Brain
7.6.1 Overview
7.6.2 Brain: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Kidney
7.7.1 Overview
7.7.2 Kidney: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8. Organoids Services Market Analysis – by Application
8.1 Developmental Biology Disease
8.1.1 Overview
8.1.2 Developmental Biology Disease: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Pathology of Infectious Disease
8.2.1 Overview
8.2.2 Pathology of Infectious Disease: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Regenerative Medicine
8.3.1 Overview
8.3.2 Regenerative Medicine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Drug Toxicity and Efficacy Testing
8.4.1 Overview
8.4.2 Drug Toxicity and Efficacy Testing: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Drug Discovery and Personalized Medicine
8.5.1 Overview
8.5.2 Drug Discovery and Personalized Medicine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
9. Organoids Services Market Analysis – by Source
9.1 Pluripotent Stem Cells
9.1.1 Overview
9.1.2 Pluripotent Stem Cells: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Organ Specific Adult Stem Cell
9.2.1 Overview
9.2.2 Organ Specific Adult Stem Cell: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10. Organoids Services Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Organoids Services Market Overview
10.2.2 North America: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Organoids Services Market Breakdown, by Type
10.2.3.1 North America: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.2.4 North America: Organoids Services Market Breakdown, by Application
10.2.4.1 North America: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.2.5 North America: Organoids Services Market Breakdown, by Source
10.2.5.1 North America: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.2.6 North America: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.2.6.1 North America: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.2.6.2 United States: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.2.1 United States: Organoids Services Market Breakdown, by Type
10.2.6.2.2 United States: Organoids Services Market Breakdown, by Application
10.2.6.2.3 United States: Organoids Services Market Breakdown, by Source
10.2.6.3 Canada: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.3.1 Canada: Organoids Services Market Breakdown, by Type
10.2.6.3.2 Canada: Organoids Services Market Breakdown, by Application
10.2.6.3.3 Canada: Organoids Services Market Breakdown, by Source
10.2.6.4 Mexico: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.4.1 Mexico: Organoids Services Market Breakdown, by Type
10.2.6.4.2 Mexico: Organoids Services Market Breakdown, by Application
10.2.6.4.3 Mexico: Organoids Services Market Breakdown, by Source
10.3 Europe
10.3.1 Europe Organoids Services Market Overview
10.3.2 Europe: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Organoids Services Market Breakdown, by Type
10.3.3.1 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.3.4 Europe: Organoids Services Market Breakdown, by Application
10.3.4.1 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.3.5 Europe: Organoids Services Market Breakdown, by Source
10.3.5.1 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.3.6 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.3.6.1 Europe: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.3.6.2 Germany: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.2.1 Germany: Organoids Services Market Breakdown, by Type
10.3.6.2.2 Germany: Organoids Services Market Breakdown, by Application
10.3.6.2.3 Germany: Organoids Services Market Breakdown, by Source
10.3.6.3 United Kingdom: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.3.1 United Kingdom: Organoids Services Market Breakdown, by Type
10.3.6.3.2 United Kingdom: Organoids Services Market Breakdown, by Application
10.3.6.3.3 United Kingdom: Organoids Services Market Breakdown, by Source
10.3.6.4 France: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.4.1 France: Organoids Services Market Breakdown, by Type
10.3.6.4.2 France: Organoids Services Market Breakdown, by Application
10.3.6.4.3 France: Organoids Services Market Breakdown, by Source
10.3.6.5 Italy: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.5.1 Italy: Organoids Services Market Breakdown, by Type
10.3.6.5.2 Italy: Organoids Services Market Breakdown, by Application
10.3.6.5.3 Italy: Organoids Services Market Breakdown, by Source
10.3.6.6 Spain: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.6.1 Spain: Organoids Services Market Breakdown, by Type
10.3.6.6.2 Spain: Organoids Services Market Breakdown, by Application
10.3.6.6.3 Spain: Organoids Services Market Breakdown, by Source
10.3.6.7 Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.7.1 Rest of Europe: Organoids Services Market Breakdown, by Type
10.3.6.7.2 Rest of Europe: Organoids Services Market Breakdown, by Application
10.3.6.7.3 Rest of Europe: Organoids Services Market Breakdown, by Source
10.4 Asia Pacific
10.4.1 Asia Pacific Organoids Services Market Overview
10.4.2 Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Organoids Services Market Breakdown, by Type
10.4.3.1 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.4.4 Asia Pacific: Organoids Services Market Breakdown, by Application
10.4.4.1 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.4.5 Asia Pacific: Organoids Services Market Breakdown, by Source
10.4.5.1 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.4.6 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.4.6.1 Asia Pacific: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.4.6.2 Japan: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.2.1 Japan: Organoids Services Market Breakdown, by Type
10.4.6.2.2 Japan: Organoids Services Market Breakdown, by Application
10.4.6.2.3 Japan: Organoids Services Market Breakdown, by Source
10.4.6.3 China: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.3.1 China: Organoids Services Market Breakdown, by Type
10.4.6.3.2 China: Organoids Services Market Breakdown, by Application
10.4.6.3.3 China: Organoids Services Market Breakdown, by Source
10.4.6.4 India: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.4.1 India: Organoids Services Market Breakdown, by Type
10.4.6.4.2 India: Organoids Services Market Breakdown, by Application
10.4.6.4.3 India: Organoids Services Market Breakdown, by Source
10.4.6.5 South Korea: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.5.1 South Korea: Organoids Services Market Breakdown, by Type
10.4.6.5.2 South Korea: Organoids Services Market Breakdown, by Application
10.4.6.5.3 South Korea: Organoids Services Market Breakdown, by Source
10.4.6.6 Australia: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.6.1 Australia: Organoids Services Market Breakdown, by Type
10.4.6.6.2 Australia: Organoids Services Market Breakdown, by Application
10.4.6.6.3 Australia: Organoids Services Market Breakdown, by Source
10.4.6.7 Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.7.1 Rest of APAC: Organoids Services Market Breakdown, by Type
10.4.6.7.2 Rest of APAC: Organoids Services Market Breakdown, by Application
10.4.6.7.3 Rest of APAC: Organoids Services Market Breakdown, by Source
10.5 Middle East and Africa
10.5.1 Middle East and Africa Organoids Services Market Overview
10.5.2 Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 Middle East and Africa: Organoids Services Market Breakdown, by Type
10.5.3.1 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.5.4 Middle East and Africa: Organoids Services Market Breakdown, by Application
10.5.4.1 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.5.5 Middle East and Africa: Organoids Services Market Breakdown, by Source
10.5.5.1 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.5.6 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.5.6.1 Middle East and Africa: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.5.6.2 Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.2.1 Saudi Arabia: Organoids Services Market Breakdown, by Type
10.5.6.2.2 Saudi Arabia: Organoids Services Market Breakdown, by Application
10.5.6.2.3 Saudi Arabia: Organoids Services Market Breakdown, by Source
10.5.6.3 South Africa: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.3.1 South Africa: Organoids Services Market Breakdown, by Type
10.5.6.3.2 South Africa: Organoids Services Market Breakdown, by Application
10.5.6.3.3 South Africa: Organoids Services Market Breakdown, by Source
10.5.6.4 United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: Organoids Services Market Breakdown, by Type
10.5.6.4.2 United Arab Emirates: Organoids Services Market Breakdown, by Application
10.5.6.4.3 United Arab Emirates: Organoids Services Market Breakdown, by Source
10.5.6.5 Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Type
10.5.6.5.2 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Application
10.5.6.5.3 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Source
10.6 South and Central America
10.6.1 South and Central America Organoids Services Market Overview
10.6.2 South and Central America: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 South and Central America: Organoids Services Market Breakdown, by Type
10.6.3.1 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Type
10.6.4 South and Central America: Organoids Services Market Breakdown, by Application
10.6.4.1 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Application
10.6.5 South and Central America: Organoids Services Market Breakdown, by Source
10.6.5.1 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Source
10.6.6 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.6.6.1 South and Central America: Organoids Services Market – Revenue and Forecast Analysis – by Country
10.6.6.2 Brazil: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.2.1 Brazil: Organoids Services Market Breakdown, by Type
10.6.6.2.2 Brazil: Organoids Services Market Breakdown, by Application
10.6.6.2.3 Brazil: Organoids Services Market Breakdown, by Source
10.6.6.3 Argentina: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.3.1 Argentina: Organoids Services Market Breakdown, by Type
10.6.6.3.2 Argentina: Organoids Services Market Breakdown, by Application
10.6.6.3.3 Argentina: Organoids Services Market Breakdown, by Source
10.6.6.4 Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: Organoids Services Market Breakdown, by Type
10.6.6.4.2 Rest of South and Central America: Organoids Services Market Breakdown, by Application
10.6.6.4.3 Rest of South and Central America: Organoids Services Market Breakdown, by Source
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Organoids Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Sino Biological Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Eurofins Scientific SE
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Molecular Devices, LLC.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 InSphero
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cyprio
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 InnoSer
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 LABTOO
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CUSABIO TECHNOLOGY LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Oncodesign Services
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The the Reporting Teams
13.2 Glossary of Terms
Table 1. Organoids Services Market Segmentation
Table 2. Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Organoids Services Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Organoids Services Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 5. Organoids Services Market – Revenue and Forecast to 2031 (US$ Million) – by Source
Table 6. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 7. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 8. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 9. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 10. United States: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 11. United States: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 12. United States: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 13. Canada: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 14. Canada: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. Canada: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 16. Mexico: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 17. Mexico: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 18. Mexico: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 19. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 20. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 21. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 22. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 23. Germany: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 24. Germany: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 25. Germany: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 26. United Kingdom: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 27. United Kingdom: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 28. United Kingdom: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 29. France: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 30. France: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 31. France: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 32. Italy: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 33. Italy: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 34. Italy: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 35. Spain: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 36. Spain: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 37. Spain: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 38. Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 39. Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 40. Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 41. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 42. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 43. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 44. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 45. Japan: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 46. Japan: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 47. Japan: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 48. China: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 49. China: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 50. China: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 51. India: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 52. India: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 53. India: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 54. South Korea: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 55. South Korea: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 56. South Korea: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 57. Australia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 58. Australia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 59. Australia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 60. Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 61. Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 62. Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 63. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 64. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 65. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 66. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 67. Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 68. Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 69. Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 70. South Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 71. South Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 72. South Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 73. United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 74. United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 75. United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 76. Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 77. Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 78. Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 79. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 80. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 81. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 82. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 83. Brazil: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 84. Brazil: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 85. Brazil: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 86. Argentina: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 87. Argentina: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 88. Argentina: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 89. Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 90. Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 91. Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million) – by Source
Table 92. Recent Organic Growth Strategies in Organoids Services Market
Table 93. Recent Inorganic Growth Strategies in the Organoids Services Market
Table 94. Glossary of Terms, Organoids Services Market
Figure 1. Organoids Services Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Organoids Services Market Revenue (US$ Million), 2021–2031
Figure 5. Organoids Services Market Share (%) – by Type (2023 and 2031)
Figure 6. Intestine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Liver: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Stomach: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Pancreas: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Lung: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Brain: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Kidney: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Organoids Services Market Share (%) – by Application (2023 and 2031)
Figure 15. Developmental Biology Disease: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Pathology of Infectious Disease: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Regenerative Medicine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Drug Toxicity and Efficacy Testing: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Drug Discovery and Personalized Medicine: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Organoids Services Market Share (%) – by Source (2023 and 2031)
Figure 22. Pluripotent Stem Cells: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Organ Specific Adult Stem Cell: Organoids Services Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Organoids Services Market Breakdown by Region, 2023 and 2031 (%)
Figure 25. North America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 26. North America: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 27. North America: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 28. North America: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 29. North America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 30. United States: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Canada: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Mexico: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 35. Europe: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 36. Europe: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 37. Europe: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 38. Germany: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. United Kingdom: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. France: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Italy: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Spain: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Rest of Europe: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Asia Pacific: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Asia Pacific: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 46. Asia Pacific: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 47. Asia Pacific: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 48. Asia Pacific: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 49. Japan: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. China: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. India: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 52. South Korea: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. Australia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. Rest of APAC: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Middle East and Africa: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 57. Middle East and Africa: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 58. Middle East and Africa: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 59. Middle East and Africa: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 60. Saudi Arabia: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 61. South Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 62. United Arab Emirates: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 63. Rest of Middle East and Africa: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 64. South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 65. South and Central America: Organoids Services Market Breakdown, by Type (2023 and 2031)
Figure 66. South and Central America: Organoids Services Market Breakdown, by Application (2023 and 2031)
Figure 67. South and Central America: Organoids Services Market Breakdown, by Source (2023 and 2031)
Figure 68. South and Central America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 69. Brazil: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. Argentina: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. Rest of South and Central America: Organoids Services Market – Revenue and Forecast to 2031(US$ Million)
Figure 72. Growth Strategies in Organoids Services Market
The List of Companies – Caseinates Market
o Polsero Sp Zoo
o EPI Ingredients SAS
o Royal FrieslandCampina NV
o AMCO Proteins
o Fonterra Co-Operative Group Ltd
o Agrocomplex SP Zoo
o Milk Specialties Global
o Farbest-Tallman Foods Corp
o Erie Foods International Inc
o Armor Proteines SAS
o Glenstal Foods
o Tatua Co-operative Dairy Co Ltd
o Ornua Co-operative Ltd
o Lactoprot Deutschland GmbH
o Drytech Processes Pvt Ltd
You must be logged in to post a review.
Reviews
There are no reviews yet.